These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 22455398)
1. Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52. Gopalakrishnan R; Kozany C; Wang Y; Schneider S; Hoogeland B; Bracher A; Hausch F J Med Chem; 2012 May; 55(9):4123-31. PubMed ID: 22455398 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52. Gopalakrishnan R; Kozany C; Gaali S; Kress C; Hoogeland B; Bracher A; Hausch F J Med Chem; 2012 May; 55(9):4114-22. PubMed ID: 22455444 [TBL] [Abstract][Full Text] [Related]
3. Fluorescent probes to characterise FK506-binding proteins. Kozany C; März A; Kress C; Hausch F Chembiochem; 2009 May; 10(8):1402-10. PubMed ID: 19418507 [TBL] [Abstract][Full Text] [Related]
4. FKBP family proteins: immunophilins with versatile biological functions. Kang CB; Hong Y; Dhe-Paganon S; Yoon HS Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947 [TBL] [Abstract][Full Text] [Related]
5. Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51. Gaali S; Feng X; Hähle A; Sippel C; Bracher A; Hausch F J Med Chem; 2016 Mar; 59(6):2410-22. PubMed ID: 26954324 [TBL] [Abstract][Full Text] [Related]
6. Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control. Wang Y; Kirschner A; Fabian AK; Gopalakrishnan R; Kress C; Hoogeland B; Koch U; Kozany C; Bracher A; Hausch F J Med Chem; 2013 May; 56(10):3922-35. PubMed ID: 23647266 [TBL] [Abstract][Full Text] [Related]
7. The prospect of FKBP51 as a drug target. Schmidt MV; Paez-Pereda M; Holsboer F; Hausch F ChemMedChem; 2012 Aug; 7(8):1351-9. PubMed ID: 22581765 [TBL] [Abstract][Full Text] [Related]
9. Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90. Bracher A; Kozany C; Thost AK; Hausch F Acta Crystallogr D Biol Crystallogr; 2011 Jun; 67(Pt 6):549-59. PubMed ID: 21636895 [TBL] [Abstract][Full Text] [Related]
17. Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein. Juli C; Sippel M; Jäger J; Thiele A; Weiwad M; Schweimer K; Rösch P; Steinert M; Sotriffer CA; Holzgrabe U J Med Chem; 2011 Jan; 54(1):277-83. PubMed ID: 21142106 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins. Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100 [TBL] [Abstract][Full Text] [Related]
19. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. Van Duyne GD; Standaert RF; Karplus PA; Schreiber SL; Clardy J J Mol Biol; 1993 Jan; 229(1):105-24. PubMed ID: 7678431 [TBL] [Abstract][Full Text] [Related]
20. FK506 binding proteins as targets in anticancer therapy. Romano S; Di Pace A; Sorrentino A; Bisogni R; Sivero L; Romano MF Anticancer Agents Med Chem; 2010 Nov; 10(9):651-6. PubMed ID: 21182472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]